Submit Manuscript now
Impact Factor 2.6

Month: May 2020

Does Measured Aggression with Stereotactic Hypo Fractionated Radiotherapy and TACE Allow Liver Transplant in Patients with Hepatocellular Carcinoma with Portal Vein Tumour Thrombus – A Retrospective Study

Leave a Comment / Issue 3 Articles, Volume 4 / By

Patients with liver confined HCC with PVTT and minimum 1000 cc volume of uninvolved cirrhotic liver underwent SHORT and TACE, former administered using Rapid Arc, dose 32-50Gy in 5-14 fractions. TACE was performed using gel foam slurry, Inj. C is platinum and PVA. Liver transplant was performed on radiological evidence of recanalization or conversion to …

Does Measured Aggression with Stereotactic Hypo Fractionated Radiotherapy and TACE Allow Liver Transplant in Patients with Hepatocellular Carcinoma with Portal Vein Tumour Thrombus – A Retrospective Study Read More »

An Unusual Cause of Abdominal Pain: Valentino’s Syndrome. A Case Report

Leave a Comment / Issue 2 Articles, Volume 4 / By

Valentino’s syndrome is a rare entity that can mimic an acute appendicitis caused by the presence of a peptic ulcer which perforated appendicitis causes reactive drainage. Present a case 52- year-old male with clinical symptoms, radiographic and ultrasonographic data appendicitis, which is subjec- ted to laparotomy finding chemical periappendicitis attended by sliding FID turbid liquid …

An Unusual Cause of Abdominal Pain: Valentino’s Syndrome. A Case Report Read More »

The Effect of Long-Term Human Albumin Administration on the Mortality of Adult Patients with De Compensated Liver Cirrhosis: A Meta-Analysis and Systematic Review

Leave a Comment / Issue 2 Articles, Volume 4 / By

Liver disease accounts for approximately 2 million deaths per year worldwide, 1 million due to complications of cirrhosis. Mortality trends in cirrhosis have been increasing in the Phi- lippines; data from 1990 to 2010 showed that there has been an overall increase of mortality by 53.7%. One of the promising treatment options for patients with …

The Effect of Long-Term Human Albumin Administration on the Mortality of Adult Patients with De Compensated Liver Cirrhosis: A Meta-Analysis and Systematic Review Read More »

What Our Author Say's

I am glad that I found this platform. It was easy to get my research published and I was guided at every step. I highly recommend them.
Shuang-Qin Yi
am grateful to the Japanese Journal of Gastroenterology and Hepatology for helping me with my research and publishing it. Looking forward to more work with them.
Makki Fayadh
It has been a pleasure working with the Japanese Journal of Gastroenterology and Hepatology. They have been amazing in helping me with my manuscript
Han Min
I am glad that I submitted my manuscript here. They helped me make necessary edits and published the best version of it. I highly recommend them.
Sadaf Saleem

FAQ's About Jajgastrohepto

The Japanese Journal of Gastroenterology and Hepatology accepts all kinds of manuscripts, such as research, studies, reviews, clinical images, editorials, commentaries, etc.

For Detailed quotations reach out submission@jajogh.jp

It depends on the length of the manuscript and the reviews and edits needed.

We will help you with as many reviews and edits as are required to make your manuscript perfect for publication.

A good impact factor for JJGH is 2.0 as per Journal Citations Reports of 2021.

Niigata, 7F Stork Building Kagamibashi, 1230-7, 7-bancho, Kamiookawamaedori, Chuo-ku, Niigata, 951-8068, Japan.

*2021 Journal unofficial Impact Factor was established by dividing the number of articles published in 2020 with the number of times they are cited in 2021 based on Google Scholar Citation Index database. If ‘X’ is the total number of articles published in 2020 and ‘Y’ is the number of times these articles were cited in indexed journals during 2021 then, journal impact factor = Y/X.

Copyright 2018-2024 All Rights Reserved.